Correction: Suppression of mitochondrial complex i influences cell metastatic properties (PLOS ONE (2013) 8:4 (e61677) DOI: 10.1371/journal.pone.0061677);Suppression of Mitochondrial Complex I Influences Cell Metastatic Properties

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  He, Xuelian ^a,b   Zhou, Aifen ^a   Lu, Hao ^b   Chen, Yong ^b,c   Huang, Guochang ^b,d   Yue, Xin ^a   Zhao, Peiwei ^a   Wu, Yanxiang ^a  

^a Wuhan Medical and Healthcare Center for Woman and Children   (China)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; FIBRONECTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE CELL ADHESION MOLECULE; PROTEIN GRIM 19; PROTEIN NDUFS3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REPRESSION; EXTRACELLULAR MATRIX; GENE; GENE SILENCING; GRIM 19 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; METASTASIS; METASTASIS POTENTIAL; NDUFS3 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; TUMOR SPHEROID; UPREGULATION;

EID: 84876449244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0303435     Document Type: Erratum

References (23)

1. Sahai E, (2007) Illuminating the metastatic process. Nat Rev Cancer 7: 737-749.
2. Barkan D, Green JE, Chambers AF, (2010) Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46: 1181-1188.
3. Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, et al. (2012) A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun 3: 1122 doi:10.1038/ncomms2128.
4. Guo W, Giancotti FG, (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
5. Wallace DC, (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
6. Huang G, Chen Y, Lu H, Cao X, (2007) Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ 14: 327-337.
7. Pitkanen S, Robinson BH, (1996) Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345-351.
8. Verkaart S, Koopman WJ, van Emst-de Vries SE, Nijtmans LG, van den Heuvel LW, et al. (2007) Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta 1772: 373-381.
9. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, et al. (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944.
10. D'Autréaux B, Toledano MB, (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824.
11. Wu WS, (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25: 695-705.
12. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664.
13. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV, (2000) Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 275: 33416-3326.
14. Lufei C, Ma J, Huang G, Zhang T, Novotny-Diermayr V, et al. (2003) GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 22: 1325-1335.
15. Putignani L, Raffa S, Pescosolido R, Aimati L, Signore F, et al. (2008) Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria.Breast Cancer Res Treat. 110: 439-452.
16. Alchanati I, Nallar SC, Sun P, Gao L, Hu J, et al. (2006) A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 25: 7138-7147.
17. He X, Cao X, (2010) Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues. J Hum Genet 55: 507-511.
18. Putignani L, Raffa S, Pescosolido R, Rizza T, Del Chierico F, et al. (2012) Preliminary evidences on mitochondrial injury and impaired oxidative metabolism in breast cancer. Mitochondrion 12: 363-369.
19. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, et al. (2007) HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12: 230-238.
20. Kaspar M, Zardi L, Neri D, (2006) Fibronectin as target for tumor therapy. Int J Cancer 118: 1331-1339.
21. Singh P, Carraher C, Schwarzbauer JE, (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol. 26: 397-419.
22. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, et al. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598.
23. Lu H, Cao X, (2008) GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol Biol Cell 19: 1893-1902.